Provision of written informed consent (by patient or appropriate designee according to local regulations) prior to any study specific procedures.
Aged 18 years or older, male or female.
History of stable angina pectoris with angiographic evidence of CAD (diameter stenosis = 50%) in major, i.e., left main, left anterior descending, left circumflex, and right coronary arteries.
History of previous myocardial infarction (MI)
History of coronary revascularization, i.e., percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG), not including the elective PCI during the index hospitalization
Documented history of type 2 diabetes mellitus.
Post-procedural residual diameter stenosis of the treated lesions < 20% in patients with stent implantation or < 50% in those with balloon angioplasty
Post-procedural thrombolysis in myocardial infarction (TIMI) grade 3 flow in treated vessels
Negative cardiac troponin test before the index elective PCI.
Taking Clopidogrel 75 mg daily dose for at least 7 days or taking Clopidogrel 75 mg daily dose for less than 7 days but with 300 to 600 mg Clopidogrel loading dose before PCI.
Taking acetylsalicylic acid (ASA) 100 mg daily treatment for at least 7 days or taking ASA 100 mg daily dose for less than 7 days but with 300 mg ASA loading dose before PCI.
have a negative urine or blood pregnancy test at enrolment and prior to randomization;
currently be using a hormonal contraceptive and agree to continue its use in addition to using double-barrier local contraception (i.e., intra-uterine device plus spermicidal and condom for male partner) from screening through study completion.

NCT02748330_inc_T2
Person
Aged
NCT02748330_inc_T3
Value
18 years or older
NCT02748330_inc_T4
Person
male
NCT02748330_inc_T5
Person
female
NCT02748330_inc_T6
Condition
stable angina pectoris
NCT02748330_inc_T7
Qualifier
angiographic evidence
NCT02748330_inc_T8
Condition
CAD
NCT02748330_inc_T9
Observation
diameter stenosis
NCT02748330_inc_T10
Multiplier
= 50%
NCT02748330_inc_T11
Qualifier
right coronary arteries
NCT02748330_inc_T12
Qualifier
ft circumflex, ronary arteries.
NCT02748330_inc_T13
Qualifier
ft anterior descending, ronary arteries.
NCT02748330_inc_T14
Qualifier
ft main, ronary arteries.
NCT02748330_inc_T16
Scope
left main, left anterior descending, left circumflex, and right coronary arteries
NCT02748330_inc_T17
Qualifier
jor, ronary arteries.
NCT02748330_inc_T18
Condition
myocardial infarction
NCT02748330_inc_T19
Condition
MI
NCT02748330_inc_T20
Procedure
coronary revascularization
NCT02748330_inc_T21
Procedure
percutaneous coronary intervention
NCT02748330_inc_T22
Procedure
PCI
NCT02748330_inc_T23
Procedure
coronary artery bypass graft
NCT02748330_inc_T24
Procedure
CABG
NCT02748330_inc_T25
Negation
not
NCT02748330_inc_T26
Procedure
PCI
NCT02748330_inc_T27
Qualifier
elective
NCT02748330_inc_T28
Temporal
during the index hospitalization
NCT02748330_inc_T29
Reference_point
index hospitalization
NCT02748330_inc_T30
Scope
percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG), not including the elective PC
NCT02748330_inc_T31
Condition
type 2 diabetes mellitus
NCT02748330_inc_T32
Observation
Post-procedural residual diameter stenosis
NCT02748330_inc_T33
Condition
lesions
NCT02748330_inc_T34
Qualifier
treated
NCT02748330_inc_T35
Value
< 20%
NCT02748330_inc_T36
Procedure
stent implantation
NCT02748330_inc_T37
Procedure
balloon angioplasty
NCT02748330_inc_T38
Value
< 50%
NCT02748330_inc_T39
Condition
lesions
NCT02748330_inc_T40
Observation
Post-procedural residual diameter stenosis
NCT02748330_inc_T41
Condition
Post-procedural thrombolysis
NCT02748330_inc_T42
Condition
myocardial infarction
NCT02748330_inc_T43
Measurement
ial infarction (TIMI)  flo
NCT02748330_inc_T44
Value
3
NCT02748330_inc_T45
Qualifier
treated vessels
NCT02748330_inc_T47
Measurement
cardiac troponin test
NCT02748330_inc_T48
Value
Negative
NCT02748330_inc_T49
Temporal
before the index elective PCI.
NCT02748330_inc_T50
Reference_point
index elective PCI
NCT02748330_inc_T51
Procedure
PCI
NCT02748330_inc_T46
Measurement
TIMI
NCT02748330_inc_T52
Drug
Clopidogrel
NCT02748330_inc_T53
Multiplier
75 mg
NCT02748330_inc_T54
Multiplier
daily
NCT02748330_inc_T55
Temporal
for at least 7 days
NCT02748330_inc_T56
Drug
Clopidogrel
NCT02748330_inc_T57
Multiplier
75 mg
NCT02748330_inc_T58
Multiplier
daily
NCT02748330_inc_T59
Temporal
for less than 7 days
NCT02748330_inc_T60
Drug
Clopidogrel
NCT02748330_inc_T61
Multiplier
300 to 600 mg
NCT02748330_inc_T62
Temporal
before PCI
NCT02748330_inc_T63
Reference_point
PCI
NCT02748330_inc_T64
Procedure
PCI
NCT02748330_inc_T65
Scope
Clopidogrel 75 mg daily dose for less than 7 days but with 300 to 600 mg Clopidogrel loading dose before PCI.
NCT02748330_inc_T66
Drug
acetylsalicylic acid
NCT02748330_inc_T67
Drug
ASA
NCT02748330_inc_T68
Multiplier
100 mg
NCT02748330_inc_T69
Multiplier
daily
NCT02748330_inc_T70
Temporal
for at least 7 days
NCT02748330_inc_T71
Drug
ASA
NCT02748330_inc_T72
Multiplier
100 mg
NCT02748330_inc_T73
Multiplier
daily
NCT02748330_inc_T74
Temporal
for less than 7 days
NCT02748330_inc_T75
Drug
ASA
NCT02748330_inc_T76
Multiplier
300 mg
NCT02748330_inc_T77
Temporal
before PCI
NCT02748330_inc_T78
Reference_point
PCI
NCT02748330_inc_T79
Procedure
PCI
NCT02748330_inc_T80
Scope
ASA 100 mg daily dose for less than 7 days but with 300 mg ASA loading dose before PCI